28.95 USD
+0.52 (+1.83%)
29.35 USD
+0.4 (+1.38%)
Taking everything into account, TCMD scores 6 out of 10 in our fundamental rating. TCMD was compared to 187 industry peers in the Health Care Equipment & Supplies industry. TCMD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TCMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes TCMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
TCMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TCMD reported negative net income in multiple years.
TCMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.01%, TCMD belongs to the top of the industry, outperforming 87.70% of the companies in the same industry.
TCMD has a better Return On Equity (8.86%) than 82.89% of its industry peers.
TCMD's Return On Invested Capital of 7.56% is amongst the best of the industry. TCMD outperforms 82.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TCMD has a better Profit Margin (5.83%) than 78.07% of its industry peers.
In the last couple of years the Profit Margin of TCMD has remained more or less at the same level.
TCMD has a better Operating Margin (7.39%) than 72.73% of its industry peers.
In the last couple of years the Operating Margin of TCMD has grown nicely.
Looking at the Gross Margin, with a value of 49.88%, TCMD is in line with its industry, outperforming 43.32% of the companies in the same industry.
TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TCMD is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TCMD has been increased compared to 5 years ago.
TCMD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 9.36 indicates that TCMD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.36, TCMD belongs to the top of the industry, outperforming 89.30% of the companies in the same industry.
TCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.36 |
ROIC/WACC0.87
WACC8.68%
2.3 Liquidity
A Current Ratio of 3.61 indicates that TCMD has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.61, TCMD is doing good in the industry, outperforming 62.57% of the companies in the same industry.
A Quick Ratio of 3.20 indicates that TCMD has no problem at all paying its short term obligations.
TCMD has a better Quick ratio (3.20) than 67.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.67% over the past year.
Measured over the past 5 years, TCMD shows a small growth in Earnings Per Share. The EPS has been growing by 4.86% on average per year.
Looking at the last year, TCMD shows a quite strong growth in Revenue. The Revenue has grown by 9.28% in the last year.
Measured over the past years, TCMD shows a quite strong growth in Revenue. The Revenue has been growing by 9.11% on average per year.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
Based on estimates for the next years, TCMD will show a very strong growth in Earnings Per Share. The EPS will grow by 20.90% on average per year.
The Revenue is expected to grow by 8.94% on average over the next years. This is quite good.
EPS Next Y14.64%
EPS Next 2Y16.58%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 37.60, the valuation of TCMD can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of TCMD indicates a somewhat cheap valuation: TCMD is cheaper than 71.12% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.43. TCMD is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 30.00, TCMD can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, TCMD is valued a bit cheaper than 72.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.66. TCMD is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.6 | ||
| Fwd PE | 30 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued a bit cheaper than 78.61% of the companies in the same industry.
TCMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TCMD is cheaper than 93.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.42 | ||
| EV/EBITDA | 18.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
TCMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 20.90% in the coming years.
PEG (NY)2.57
PEG (5Y)7.73
EPS Next 2Y16.58%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
28.95
+0.52 (+1.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.68%
Ins Owners2.66%
Ins Owner Change-0.47%
Market Cap646.74M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target24.48 (-15.44%)
Short Float %8.55%
Short Ratio4.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)42.57%
PT rev (3m)77.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)29.13%
EPS NY rev (3m)26.27%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.99%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.6 | ||
| Fwd PE | 30 | ||
| P/S | 2.08 | ||
| P/FCF | 16.42 | ||
| P/OCF | 15.45 | ||
| P/B | 3.16 | ||
| P/tB | 4.83 | ||
| EV/EBITDA | 18.52 |
EPS(TTM)0.77
EY2.66%
EPS(NY)0.96
Fwd EY3.33%
FCF(TTM)1.76
FCFY6.09%
OCF(TTM)1.87
OCFY6.47%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.57
PEG (5Y)7.73
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.36 |
F-Score7
WACC8.68%
ROIC/WACC0.87
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.64%
EPS Next 2Y16.58%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status for TCMD stock?
ChartMill assigns a valuation rating of 4 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
What are the PE and PB ratios of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 37.6 and the Price/Book (PB) ratio is 3.16.
Can you provide the financial health for TCMD stock?
The financial health rating of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 8 / 10.